Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology PressReach · Nov 22, 2024
Real Relax Launches Black Friday Event with Exclusive Deals on Premium Massage Chairs PressReach · Nov 22, 2024
Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market PressReach · Nov 22, 2024
Avirmax Biopharma Announces First Patient Dosed in Clinical Trial of ABI-110, a Groundbreaking Gene Therapy for Wet AMD Including PCV PressReach · Nov 22, 2024
Vicebio Advances Clinical Study of RSV/hMPV Bivalent Vaccine & Strengthens Board with Appointments of World Class Veterans PressReach · Nov 21, 2024
Capital Rx Achieves Place on the Deloitte Technology Fast 500™ for Third Year in a Row PressReach · Nov 21, 2024
ODAIA Announces Voice AI for Biopharma to Advance Healthcare Professional Engagement PressReach · Nov 20, 2024
Riceland, Hill's Pet Nutrition Announce Sustainably Grown Rice Collaboration PressReach · Nov 20, 2024
ACTO JOINS VEEVA AI PARTNER PROGRAM TO STRENGTHEN FIELD TEAM MESSAGING DURING FACE-TO-FACE HCP INTERACTIONS PressReach · Nov 19, 2024
AMCOR AND BERRY TO COMBINE IN AN ALL-STOCK TRANSACTION, CREATING A GLOBAL LEADER IN CONSUMER AND HEALTHCARE PACKAGING SOLUTIONS PressReach · Nov 19, 2024
